ClinicalTrialsFinder

Lung Cancer, Non-squamous, Non-small Cell Clinical Trials in Los Angeles, California

1 recruitingLos Angeles, California

Showing 1–1 of 1 trials

Recruiting
Phase 3

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim416 enrolled162 locationsNCT06151574